Salminen, Aaro V.
Winkelmann, Juliane
Article History
First Online: 9 November 2018
Compliance with Ethical Standards
:
: Aaro V. Salminen declares no potential conflict of interest. Juliane Winkelmann has received speaker honoraria from Bayer and UCB, as well as research grants from Else Kröner Foundation and German Research Foundation (DFG). Juliane Winkelmann also has a patent filed related to Thalidomide in RLS pending.
: This article does not contain any studies with human or animal subjects performed by any of the authors.